3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- manufacturers
|
| 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- Basic information |
Product Name: | 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- | Synonyms: | GB002;PK-10571;Seralutinib;3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-;Seralutinib (GB002);Seralutinib (PK-10571;(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide;PK 10571,Seralutinib,inhibit,arterial,PDGFR,PK10571,PK-10571,PAH,Pulmonary,hypertension,GB 002,GB-002,Inhibitor,Platelet-derived growth factor receptor | CAS: | 1619931-27-9 | MF: | C27H27N5O3 | MW: | 469.54 | EINECS: | | Product Categories: | | Mol File: | 1619931-27-9.mol | |
| 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- Chemical Properties |
Boiling point | 601.4±55.0 °C(Predicted) | density | 1.252±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 100 mg/mL (212.98 mM; Need ultrasonic) | form | Solid | pka | 12.16±0.70(Predicted) | color | White to light yellow |
| 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- Usage And Synthesis |
| 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- Preparation Products And Raw materials |
|